Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aker Solutions Awarded Contract for the Brevik Carbon Capture Project

December 22, 2020 – Aker Solutions has secured a contract from Aker Carbon Capture for engineering, procurement and management assistance to realize the CO2 capture plant at Norcem’s cement factory in Brevik, Norway. The project will start in January 2021 and work will be completed in 2024. The contract has a value of about NOK 500 million.The plant will become the world’s first large-scale capture plant at a cement producer, capturing some 400,000 metric tons of CO2 annually.  Aker Carbon Capture is the main contractor for engineering, procurement and construction (EPC) and will apply

INVITATION: INVISIO invites you to a conference call December 22 at 10:00 CET

INVISIO is pleased to invite press, investors and analysts to a conference call on December 22 at 10.00 CET where CEO Lars Højgård Hansen will present the acquisition of Racal Acoustics.The conference call, which will be held in English, will begin with a presentation of the acquisition followed by a Q&A session. Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.Standard international: +44 (0) 2071928338 Sweden (Local number):

INVISIO acquires Racal Acoustics, a world-leading UK-based supplier of communication and hearing protection solutions

INVISIO has today signed an agreement to acquire all the shares in Racal Acoustics, a UK-based supplier of communication and hearing protection systems for high noise environments, with annual sales of approximately SEK 130 million. Racal Acoustics Ltd, a subsidiary of TransDigm Group Inc. prior to INVISIO’s acquisition, is a world-leading brand with a history of more than 100 years in the design, develop­ment and manufacture of communication and hearing protection systems, focused on audio ancillary equipment for the military, first responder and aviation sectors. The London-based

BAKKAFROST: Share Savings Plan Transaction

As a part of the share savings plan for employees in 2020, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 26 shares. After the transaction, he holds 4,616,755 shares. · Høgni Dahl Jakobsen, CFO, purchased 16 shares. After the transaction, he holds directly and indirectly 412 shares. · Odd Eliasen, Managing Director, purchased 21 shares. After the transaction, he holds 184,479 shares. · Annika Frederiksberg, Board Member, purchased 7 shares. After the transaction, she holds directly and indirectly 16,063 shares. The shares

Saga Pure ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice from Saga Pure ASA (the "Company") dated 21 December 2020 regarding completion of a private placement of new shares in the Company (the "Private Placement"). Øystein Stray Spetalen, director and primary insider, has on 21 December 2020 been allocated 3,000,000 shares in the Company in the Private Placement at a price of NOK 2.90 per share through his controlled company Tycoon Industrier AS. After the transaction, Øystein Stray Spetalen and associated companies have a holding of 198,391,799 shares in the Company. This information is

Saga Pure ASA - Private placement successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 21 December 2020. Reference is made to the stock exchange release from Saga Pure ASA ("SAGA " or the "Company") published on 21 December 2020 regarding a contemplated private placement (the "Private Placement"). The Company is pleased to announce that it has raised NOK 87 million in gross proceeds through the Private Placement of 30,000,000 new

ABS Awards Industry’s First AIP for Infection Mitigating Design to Samsung Heavy Industries

JDP Applies ABS Infection Mitigation Approach to Design of Vessel Accommodation and Ventilation System(HOUSTON) In an industry first, ABS has awarded Samsung Heavy Industries (SHI) Approval in Principle (AIP) for crew accommodation and ventilation systems designed to mitigate the spread of infectious diseases such as COVID-19. The AIP is the product of a joint development project (JDP) between ABS and SHI that applied the principles described in the ABS Guide for Mitigation of Infectious Disease Transmission On Board Marine and Offshore Assets to a crude oil tanker, a container carrier

Sobi appoints new Head of North America ahead of launch phase

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI ) has appointed Duane Barnes as the new Head of Sobi in North America. “Sobi in North America has gone through significant change over the past few years and has exciting launches both underway and coming up in the years ahead,” says Guido Oelkers, CEO and President of Sobi. “This is why it is such a pleasure to welcome Duane to Sobi. His experience and background will be invaluable as we continue to build our presence in the US and fulfil our commitment to further expand access to patients.” Duane was most

Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel

· Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data · Nordic Capital and Astorg will actively support and accelerate Cytel’s next phase of growth and innovation, drawing on their extensive experience of investing in healthcare and technologyNordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one

Tokmanni Group Corporation: SHARE REPURCHASE 21.12.2020

Tokmanni Group Corporation  ANNOUNCEMENT  21.12.2020 Tokmanni Group Corporation: SHARE REPURCHASE 21.12.2020 In the Helsinki Stock Exchange Trade date           21.12.2020Bourse trade         BuyShare                  TOKMANAmount             23 041 SharesAverage price/ share    15,6643 EURTotal cost            360 921,14 EUR Tokmanni Group Corporation now holds a total of 29 508 sharesincluding the shares repurchased on 21.12.2020 On behalf of Tokmanni Group Corporation

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 21.12.2020

United Bankers Corporation NOTIFICATION 21.12.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 21.12.2020 Date 21.12.2020Exchange transaction BuyShare class UNIAVAmount 592Average price/share 9.9451 EURHighest price/share 10.0000 EURLowest price/share 9.9000 EURTotal price 6,683.11 EUR The shares held by United Bankers Corporation on 21.12.2020: UNIAV 37,460   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Changes to Cantargia’s nomination committee

In October 2020, Cantargia’s AB (publ) nomination committee ahead of the 2021 annual general meeting was appointed in accordance with the guidelines established by the 2020 annual general meeting, Today, Cantargia announces that the committee member Alexander Mata (appointed by Alecta Pensionsförsäkring, Ömsesidigt) resigns from the nomination committee and that Alecta Pensionsförsäkring, Ömsesidigt has appointed Mikael Wiberg as a new member. Going forward, the nomination committee comprises Marianne Nilsson (Swedbank Robur Fonder), Jannis Kitsakis (Fjärde AP-fonden), Mikael Wiberg (

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Nordea Bank AbpStock exchange release – Major shareholder announcements21 December 2020 at 18.30 EET Nordea Bank Abp has on 21 December 2020 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights crossed the threshold of 5 per cent on 18 December 2020. According to the notification, the total number of Nordea Bank Abp’s shares and voting rights held directly or through financial instruments by BlackRock, Inc. and its funds was 5.05 per cent on 18

Relais Group Plc's financial reporting and Annual General Meeting in 2021

Relais Group Plc's financial reporting and Annual General Meeting in 2021 Relais Group Plc, Company release, 21.12.2020, at 18.15 Relais Group will publish its Financial Statement Release 2020 on Thursday, 25 February 2021. The Financial Statements and the Report of the Board of Directors for 2020 will be published on Monday, 8 March 2021 on the Company's website. The Half-Year Financial Report from January-June 2021 will be published on Thursday, 12 August 2021. The Annual General Meeting 2021 The Annual General Meeting is planned to be held on Tuesday, 30 March 2021. The

SAGA PURE ASA – CONTEMPLATED EQUITY OFFERING OF UP TO 25 MILLION SHARES

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO BUY, SELL OR SUBSCRIBE FOR ANY SECURITIES DESCRIBED HEREIN. Oslo, 21 December 2020 Saga Pure ASA ("SAGA" or the "Company") (OSE: "SAGA") is contemplating an equity offering through the issue of up to 25 million shares (the “Offer Shares”) at a price per Offer Share to be determined in a

Oncopeptides enrolls the first patient in the phase 3 LIGHTHOUSE combination study in multiple myeloma

STOCKHOLM — December 21, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the first patient has been dosed in the phase 3 LIGHTHOUSE study, evaluating the efficacy and safety of a triple combination therapy with melflufen plus dexamethasone and subcutaneous daratumumab compared to daratumumab alone. The phase 3 LIGHTHOUSE study is a randomized, open-label study in patients with relapsed refractory multiple myeloma who are refractory to an immunomodulatory agent and a proteasome inhibitor or who have had at least three prior lines of therapy, including these agents.

FLNG – Repurchase of shares

December 21, 2020 Hamilton, Bermuda Flex LNG Ltd. (“Flex LNG” or the “Company”) announces that the Company has today purchased 26,750 of the Company’s own common stocks. The shares have been bought on the Oslo Stock Exchange at an average price of NOK 74.61 per share. After this transaction Flex LNG holds a total of 176,750 own shares. The transaction is part of the share buyback program announced on November 19, 2020. For more info please contact: Harald Gurvin, Chief Financial Officer of Flex LNG Management AS. Telephone +47 23 11 40 00 This information is subject to the

Vitec Software Group AB (publ): Convertible bonds fully converted

The convertible bonds for Vitec employees with start January 2018 are fully converted.The number of B shares has increased by 200,206, and the share capital increased by SEK 20,020.60. Total equity has increased by 21.2 MSEK. The total number of shares after conversion amounts to 32,773,422 of which 3,050,000 are Class A-shares. The convertible program January 1, 2018 - December 31, 2020 was aimed at all employees in the Group.   For more information, please contact Patrik Fransson, IR, Vitec Software Group AB (publ), mobile, +46 76 942 85 97   About VitecVitec is market

Volati divests NaturaMed Pharma and closes the Consumer business area

Volati has entered into an agreement and sold all of the shares in NaturaMed Pharma (“NMP”) to Vision Healthcare. The transaction is taking place at an estimated enterprise value of EUR 6 million and is expected to generate a capital loss of approximately SEK 95 million and a positive liquidity effect of approximately SEK 55 million for Volati. In connection with the transaction, Volati is closing the Consumer business area. NMP is one of the Nordic region’s leading suppliers of nutritional supplements via subscription. Sales are made directly to consumers in Norway, Finland and Sweden.

#20-460 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-459 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine

As previously communicated in connection with the IPO the results from the phase II study performed by researchers at Rigshospitalet were available in 2020. Following data analysis, a scientific manuscript covering the results has been submitted by the research group to the Journal of Nuclear Medicine where it underwent a stringent peer-review process. Following this process, the manuscript has been accepted for publication in an upcoming issue of the Journal of Nuclear Medicine probably during H1 2021.The phase II study The aim of the phase II study was to evaluate the correlation

Storytel and leading Icelandic publishing house Forlagið enter into a multi-year agreement

Storytel AB (publ), Storytel Iceland and Iceland’s leading book publishing house Forlagið, have today agreed to enter into a multiannual distribution agreement. This means that the merger application for the companies, which was announced this summer, is withdrawn.On 1 July 2020, Storytel announced its intention to acquire a 70 percent majority interest in Iceland’s leading book publishing house Forlagið. The majority seller, Mál og menning Literary Society, would remain a 30 percent minority owner in Forlagið, which would operate independently from Storytel Iceland’s streaming operations

There are no items matching the current filter
There are no more items matching the current filter
Back to top